Titan Pharmaceuticals (NASDAQ:TTNP) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Free Report) in a report issued on Tuesday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Titan Pharmaceuticals Stock Up 4.6 % NASDAQ:TTNP opened at $0.48 on Tuesday. The firm’s 50 day moving average is $0.54 and its 200 day […]

Related Keywords

United States ,Canada ,Davide Lazar , ,Virtu Financial ,Securities Exchange Commission ,Renaissance Technologies ,European Union ,Titan Pharmaceuticals Inc ,Titan Pharmaceuticals Stock ,Titan Pharmaceuticals Company Profile ,Millennium Management ,Nasdaq ,News Ratings For Titan Pharmaceuticals Daily ,Hedge Funds Weigh In On Titan Pharmaceuticals ,Titan Pharmaceuticals ,Free Report ,Get Free Report ,Exchange Commission ,State Street Corp ,Titan Pharmaceuticals Daily ,Nasdaq Ttnp ,Ttnp ,Medical ,Initiated Coverage ,Stocknews Com ,